About The Pathway
The Pathway is a twice-weekly briefing for medical device and medtech leaders — the people building, scaling, and navigating one of the most complex industries in the world.
We publish two things:
Monday — Weekly Digest. The eight most important stories in medical device and medtech, curated and summarized every week. Regulatory moves, product launches, M&A, clinical data, safety signals, and market intelligence — everything you need to start the week informed.
Thursday — Field Note. One story, reported and analyzed in depth. Not aggregated, not summarized — original journalism on the issue that matters most to the industry that week.
The Pathway is written for people who don’t have time to read everything but can’t afford to miss what matters. In five minutes on a Monday morning, you’ll know more about where this industry is heading than most people in the room.
Who reads it
Medical device founders, C-suite executives, regulatory and clinical affairs leaders, commercial operators, and investors — concentrated in Class II and III device companies at every stage from pre-launch to scale. Nearly 30,000 subscribers and growing every week.
Why subscribe
The medtech industry moves fast and the signal-to-noise ratio is brutal. The Pathway exists to fix that. Every issue is edited for relevance to device and medtech leaders specifically — not broad healthcare, not pharma, not hospital administration. If you build, launch, fund, or regulate medical devices, this was written for you.
Sponsorship
The Pathway works with a small number of sponsors each month — companies whose products and services are directly relevant to medical device and medtech leaders. One sponsor per issue. No banner ads, no display advertising, no misaligned placements.
If your company serves this audience, we’d like to talk.
